ADURO BIOTECH, INC.

Profile

Company Names

ADURO BIOTECH, INC.
ADURO BIOTECH

Addresses

626 BANCROFT WAY, #3C, BERKELEY, CA 94710

626 BANCROFT WAY, SUITE 3-C, BERKELEY, CA 94710

Phone Numbers

510-848-4400

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

CALIFORNIA

Total Amount Raised:

$128,794,818.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2014-12-19 
$51,388,002.00 
$51,388,002.00 
$0.00 
Equity 
7
2014-05-30 
$40,602,333.00 
$40,602,333.00 
$0.00 
Equity 
6
2013-08-12 
$7,000,000.00 
$13,000,000.00 
$6,000,000.00 
Equity 
5
2011-10-24 
$512,100.00 
$512,100.00 
$0.00 
 
4
2011-04-15 
$25,573,536.00 
$25,729,450.00 
$155,914.00 
Equity 
3
2010-03-05 
$768,847.00 
$768,847.00 
$0.00 
 
2
2009-11-03 
$1,175,000.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2008-12-02 
$1,775,000.00 
$1,775,000.00 
$0.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DIRK 
G. 
BROCKSTEDT 
EXECUTIVE OFFICER
ADURO BIOTECH, INC.
GERALD 
DAVID 
CHAN 
DIRECTOR
ADURO BIOTECH, INC.
THOMAS 
W. 
DUBENSKY 
EXECUTIVE OFFICER
ADURO BIOTECH, INC.   |  TEMPEST THERAPEUTICS, INC.
DAVID 
 
FISCHELL 
DIRECTOR
SVELTE MEDICAL SYSTEMS INC   |  ADURO BIOTECH   |  NEURALIEVE, INC.   |  NEUROPACE INC   |  NEURALIEVE, LLC   |  ENEURA THERAPEUTICS LLC   |  ENEURA, INC.   |  ANGEL MEDICAL SYSTEMS INC   |  TETMEDICAL, INC.   |  AVERTIX MEDICAL, INC.
WILLIAM 
E. 
GIBSON 
DIRECTOR
ADURO BIOTECH
WILLIAM 
 
GREENMAN 
DIRECTOR
ADURO BIOTECH   |  ADURO BIOTECH, INC.
ROSS 
 
HAGHIGHAT 
DIRECTOR
FRX POLYMERS, INC.   |  ADURO BIOTECH   |  ADURO BIOTECH, INC.   |  ANGEL MEDICAL SYSTEMS INC   |  AVERTIX MEDICAL, INC.   |  FLUENCE CORP LTD
STEPHEN 
 
ISAACS 
EXECUTIVE OFFICER, DIRECTOR
ADURO BIOTECH, INC.
STEPHEN 
T. 
ISAACS 
EXECUTIVE OFFICER, DIRECTOR
ADURO BIOTECH   |  ADURO BIOTECH, INC.   |  X-BIOTIX THERAPEUTICS, INC.
JENNIFER 
 
LEW 
EXECUTIVE OFFICER
DYNAVAX TECHNOLOGIES CORP   |  ADURO BIOTECH, INC.   |  ANNEXON, INC.   |  BOUNDLESS BIO, INC.
RUDY 
 
MAZZOCCHI 
DIRECTOR
ADURO BIOTECH   |  TGS KNEE INNOVATIONS, INC   |  ALEXANDRIA RESEARCH TECHNOLOGIES, LLC   |  ELENZA, INC   |  NEXGEN MEDICAL SYSTEMS INC   |  DAUPHIN HEALTH, INC.   |  Q-SENSEI, CORP.   |  ESTABLISHMENT LABS HOLDINGS INC.   |  BIOMEDX GROUP, INC.   |  AGENTIX CORP.   |  ASEP MEDICAL INC.   |  PREIPO CORP
FRANK 
 
MCCORMICK 
DIRECTOR
EXELIXIS INC   |  ADURO BIOTECH   |  ADURO BIOTECH, INC.   |  AVIDITY NANOMEDICINES LLC   |  PELLEPHARM, INC.   |  OLEMA PHARMACEUTICALS, INC.   |  REMEDY PLAN, INC.   |  EXUMA BIOTECH CORP.   |  THERAS, INC.
S. 
DAVID 
MODEL 
EXECUTIVE OFFICER
ADURO BIOTECH   |  ADURO BIOTECH, INC.
SETH 
DAVID 
MODEL 
EXECUTIVE OFFICER
ADURO BIOTECH, INC.
STEPHANIE 
 
O-BRIEN 
DIRECTOR
ADURO BIOTECH   |  BIDDINGFORGOOD, INC.   |  ADURO BIOTECH, INC.   |  NATURAL POLYMER INTERNATIONAL CORP   |  APELLIS PHARMACEUTICALS, INC.   |  VIGEO THERAPEUTICS, INC.   |  PINTEON THERAPEUTICS, INC.   |  2020, INC.
DREW 
 
PARDOLL 
DIRECTOR
ADURO BIOTECH   |  DNATRIX INC
CHRISTOPHER 
D. 
RAY 
DIRECTOR
ADURO BIOTECH   |  X-BIOTIX THERAPEUTICS, INC.
GREGORY 
 
SCHAFER 
EXECUTIVE OFFICER
JENNEREX, INC.   |  ADURO BIOTECH, INC.   |  CAPRICOR THERAPEUTICS, INC.
GREGORY 
W. 
SCHAFER 
EXECUTIVE OFFICER
NILE THERAPEUTICS, INC.   |  ADURO BIOTECH, INC.
DALE 
H. 
STEVENS 
DIRECTOR
ADURO BIOTECH
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-01-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-12-19 
2014-06-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-30 
2013-09-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-12 
2013-02-12
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
2011-12-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2011-10-24 
2011-04-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
2010-04-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2010-03-05 
2009-11-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-11-03 
2009-11-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2008-12-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
39011